Biocon Biologics Limited, a unit of India’s largest biopharmaceutical company Biocon, is in talks with Asia-focused Baring Private Equity (PE) Asia to raise funding in lieu of a minority stake, multiple sources familiar with the matter told DealStreetAsia.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
